Microbiological assay for the determination of azithromycin in ophthalmic solutions

Yaoxue Xuebao

Volumn 40, Issue 6, 2005, Pages 544-549

  Salgado, Hérida Regina Nunes ^a   Roncari, Ana Flávia Ferreira ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Azithromycin; Cylinder plate method; Microbiological assay; Ophthalmic solution; Pharmaceutical dosage form; Quality control

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; EYE DROPS;

ARTICLE; BACILLUS SUBTILIS; CHEMISTRY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; QUALITY CONTROL;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACILLUS SUBTILIS; MICROBIAL SENSITIVITY TESTS; OPHTHALMIC SOLUTIONS; QUALITY CONTROL;

EID: 23044516230     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The Index Merck. 13th Ed. Whitehouse Station, 2001.
2. Wise R. The development of macrolides and related compounds [J]. J Antimicrob Chemother, 1989,23:299-300.
3. Retsema JA, Girard AE, Girard D, et al. Relationship oh high tissue concentrations of azithromycin to bacterial activity and efficacy in vivo [J]. J Antimicrob Chemother, 1990,25A:83-89.
4. Riedel KD, Wildfeuer A, Laufen H, et al. Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples [J]. J Chromatogr Biomed Appl, 1992,576(2):358-362.
5. Worth S, Erwin ME, Jones RN, et al. Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99, 219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards Susceptibility Testing Methods [J]. Diagn Microbiol Infect Dis, 1996,24:87-91.
6. Turčinov T, Pepeljnjak S. Azithromycin potency determination : Optimal conditions for microbiological diffusion method assay [J]. J Pharm Biomed Anal, 1998,17(4-5):903-910.
7. 2 chemiluminescence reaction using flow injection technique [J]. Bioorg Med Chem, 2003,11(24):5375-5380.
8. Sastre-Toraño J, Guchelaar HJ. Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl chloride and fluorescence detection [J]. J Chromatogr B, 1998,720:89-97.
9. Breier AR, Garcia CV, Oppe TP, et al. Microbiological assay for azithromycin in pharmaceutical formulations [J]. J Pharm Biomed Anal, 2002,29:957-961.
10. Farghaly OAEM, Mohamed NAL. Voltammetric determination of azithromycin at the carbon paste electrode [J]. Talanta, 2004,62(3):531-538.
11. Nigović B, Šimunić B. Voltammetric assay of azithromycin in pharmaceutical dosage forms [J]. J Pharm Biomed Anal, 2003,32(1):197-202.
12. Zubata P, Ceresole R, Rosasco MA, et al. A new HPLC method for azithromycin quantitation [J]. J Pharm Biomed Anal, 2002,27(5):833-836.
13. Shepard RM, Duthu GS, Ferraina RA, et al. High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues [J]. J Chromatogr Biomed Appl, 1991,565(1-2):321-337.
14. Raines DA, Yusuf A, Jabak MH, et al. Simultaneous high-performance liquid chromatography analysis of azithromycin and two of its metabolites in human tears and plasma [J]. Ther Drug Monit, 1998,20(6):680-684.
15. Kees F, Spangler S, Wellenhofer M. Determination of macrolides in biological matrices by high-performance liquid chromatography with electrochemical detection [J]. J Chromatogr A, 1998,812:287-293.
16. Ghandi R, Kau CL, Panchagnula R. Validated LC method for in-vitro analysis of azithromycin using electrochemical detection [J]. J Pharm Biomed Anal, 2000,23:1073-1079.
17. Taninaka T, Ohtani H, Hanada E, et al. Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection [J]. J Chromatogr B Biomed Sci Appl, 2000,738(2):405-411.
18. USP Convention. The United States Pharmacopeia [S]. 25th Ed. 2002.
19. Fouda HG, Schneider RP. Quantitative determination of the antibiotic azithromycin in human serum by high performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass spectrometry: correlation with a standard HPLC-electrochemical method [J]. Ther Drug Monit, 1995,17(2):179-183.
20. Jiao J, Carella AJ, Steeno G, et al. Optimization of triple quadrupole mass spectrometer for quantitation of trace degradants of pharmaceutical compounds [J]. Int J Mass Spectrom, 2002,216(2):209-218.
21. Blanco M, Vald SD, Bayod MS, et al. Characterization and an lisis of polymorphs by near-infrared spectrometry [J]. Anal Chim Acta, 2004,502(2):221-227.
22. AOAC. Official Methods of Analytical Chemists of AOAC [S]. 15th Ed. XVII. 1990.
23. Hewitt H. Microbiological assay: an Introduction to Quantitative Principles and Evaluation [M]. New York: Academic Press, 1977.
24. ICH. Validation on analytical procedures [A]. Commission of the European Communities. Proceedings of the International Conference on Harmonization (ICH) [C]. 1996.
25. Kanfer M, Skinner MF, Walker RB. Analysis of macrolide antibiotics [J]. J Chromatogr A, 1998,812;255-286.
26. Khashaba PY. Spectrofluorimetric analysis of certain macrolide antibiotics in bulk and pharmaceutical formulations [J]. J Pharm Biomed Anal, 2002,27:923-932.
27. Miguel L, Barbas C. LC determination of impurities in azithromycin tablets [J]. J Pharm Biomed Anal, 2003,33(2):211-217.
28. Sher H, Rau H, Greiner G, et al. Spectroscopic and polarographic investigations of copper (II)-azithromycin interactions under equilibrium conditions [J]. Int J Pharm, 1996,133(1-2):237-244.
29. Farmacopéia Brasileira [S]. 4th Ed. São Paulo: Atheneu, 1988.